Bismuth Subcitrate/Metronidazole/Tetracycline — Axcan Pharma

Axcan Pharma. Axcan presents new data on its bismuth-based triple therapy for treatment of Helicobacter pylori during digestive disease week in Orlando, Florida. Media Release: [2 pages], 18 May 1999. Available from URL: http://www.axcan.com De Boer WA, Borody TJ. Towards monotherapy for Helicobacter pylori infection: first results with a single triple capsule. Gastroenterology 114 (Suppl): 98, Part 2, 15 Apr 1998 Kler L, Edwards RC, McNeil SJ, Round P, PPAB2002 Study Group. GI262570, a tyrosine-based PPAR-gamma agonist, reduces triglycerides and increases HDL-C concentrations in patients with type 2 diabetes mellitus when combined with glibenclamide treatment. Diabetes Research and Clinical Practice 50 (Suppl 1): 39–40 (plus poster), Sep 2000